Literature DB >> 4052282

Comparison of primary plexogenic arteriopathy in adults and children. A morphometric study in 40 patients.

S Yamaki, C A Wagenvoort.   

Abstract

Pulmonary vascular changes were studied in histological sections from 15 children and 25 adults with primary plexogenic arteriopathy. The severity of medial hypertrophy and degree of vasoconstriction were measured in histological sections and there was a close correlation between these two variables in both children and adults. More advanced arterial changes, expressed as an index of pulmonary vascular disease, were more common in adults, and their severity correlated positively with the degree of medial hypertrophy. No such correlation was found in children. There were similar numbers of plexiform lesions per square centimetre in children and adults, so that the differences in the indices of pulmonary vascular disease were mainly due to the intimal changes. Concentric laminar intimal fibrosis was more severe in adults. It is suggested that intensive spastic vasoconstriction results in the development of fibrinoid necrosis and subsequently of plexiform lesions and that this may happen irrespective of the presence of severe intimal fibrosis. This suggests that children with primary plexogenic arteriopathy in whom plexiform lesions have not yet developed are more likely to respond to vasodilator treatment than are adults in whom irreversible changes associated with intimal fibrosis have developed.

Entities:  

Mesh:

Year:  1985        PMID: 4052282      PMCID: PMC481922          DOI: 10.1136/hrt.54.4.428

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  Solitary pulmonary hypertension.

Authors:  D E BEDFORD; W EVANS; D S SHORT
Journal:  Br Heart J       Date:  1957-01

2.  Ultrastructural study of contraction of pulmonary vascular smooth muscle cells.

Authors:  K P Dingemans; C A Wagenvoort
Journal:  Lab Invest       Date:  1976-09       Impact factor: 5.662

3.  Quantitative analysis of pulmonary vascular disease in complete transposition of the great arteries.

Authors:  S Yamaki; F Tezuka
Journal:  Circulation       Date:  1976-11       Impact factor: 29.690

4.  Primary pulmonary hypertension.

Authors:  G Walcott; H B Burchell; A L Brown
Journal:  Am J Med       Date:  1970-07       Impact factor: 4.965

5.  Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension.

Authors:  F S Daoud; J T Reeves; D B Kelly
Journal:  Am J Cardiol       Date:  1978-11       Impact factor: 2.778

6.  Indication for total correction of complete transposition of the great arteries with pulmonary hypertension.

Authors:  S Yamaki; T Horiuchi; E Ishizawa; H Mohri; M Fukuda; F Tezuka
Journal:  J Thorac Cardiovasc Surg       Date:  1980-06       Impact factor: 5.209

7.  A case of spontaneous resolution of idiopathic pulmonary hypertension.

Authors:  A Fujii; M Rabinovitch; E C Matthews
Journal:  Br Heart J       Date:  1981-11

8.  Plexogenic pulmonary arteriopathy: significance of medial thickness with respect to advanced pulmonary vascular lesions.

Authors:  S Yamaki; C A Wagenvoort
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

9.  Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.

Authors:  M Honey; L Cotter; N Davies; D Denison
Journal:  Thorax       Date:  1980-04       Impact factor: 9.139

10.  Regression of primary pulmonary hypertension.

Authors:  P D Bourdillon; C M Oakley
Journal:  Br Heart J       Date:  1976-03
View more
  11 in total

1.  Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors:  Robert F Wideman; Krishna R Hamal
Journal:  J Pharmacol Toxicol Methods       Date:  2011-01-26       Impact factor: 1.950

Review 2.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

3.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

Authors:  R M Tuder; B Groves; D B Badesch; N F Voelkel
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

Review 4.  Pulmonary arterial hypertension: a comparison between children and adults.

Authors:  R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal:  Eur Respir J       Date:  2011-03       Impact factor: 16.671

Review 5.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

6.  Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.

Authors:  E D Austin; J D Cogan; J D West; L K Hedges; R Hamid; E P Dawson; L A Wheeler; F F Parl; J E Loyd; J A Phillips
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

Review 7.  Pulmonary Hypertension.

Authors:  Peter Oishi; Jeffrey R Fineman
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

Review 8.  Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Norbert F Voelkel; Nobuhiro Tanabe; Koichiro Tatsumi
Journal:  Respir Res       Date:  2015-07-08

9.  In situ thrombosis of small pulmonary arteries in pulmonary hypertension developing after chemotherapy for malignancy.

Authors:  Kay Maeda; Yoshikatsu Saiki; Shigeo Yamaki
Journal:  Pulm Med       Date:  2015-01-27

10.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension in children.

Authors:  Maha Al Dabbagh; Hanna Banjar; Nasser Galal; Amjad Kouatli; Hammam Kandil; May Chehab
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.